156 related articles for article (PubMed ID: 24165995)
1. Nutrition: New diabetes nutrition recommendations--food for thought.
Koch L
Nat Rev Endocrinol; 2013 Dec; 9(12):687. PubMed ID: 24165995
[No Abstract] [Full Text] [Related]
2. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society: executive summary.
; ; Gonzalez-Campoy JM; St Jeor ST; Castorino K; Ebrahim A; Hurley D; Jovanovic L; Mechanick JI; Petak SM; Yu YH; Harris KA; Kris-Etherton P; Kushner R; Molini-Blandford M; Nguyen QT; Plodkowski R; Sarwer DB; Thomas KT;
Endocr Pract; 2013; 19(5):875-87. PubMed ID: 24121263
[No Abstract] [Full Text] [Related]
3. Editorial comments: endocrinology and metabolism 2010.
Root AW
Curr Opin Pediatr; 2010 Aug; 22(4):467-9. PubMed ID: 20631539
[No Abstract] [Full Text] [Related]
4. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society.
Gonzalez-Campoy JM; St Jeor ST; Castorino K; Ebrahim A; Hurley D; Jovanovic L; Mechanick JI; Petak SM; Yu YH; Harris KA; Kris-Etherton P; Kushner R; Molini-Blandford M; Nguyen QT; Plodkowski R; Sarwer DB; Thomas KT; ;
Endocr Pract; 2013; 19 Suppl 3():1-82. PubMed ID: 24129260
[No Abstract] [Full Text] [Related]
5. [Current therapeutics 1990-1995 in the field of endocrinology-metabolism].
Scheen AJ
Rev Med Liege; 1996 Aug; 51(8):503-9. PubMed ID: 8927870
[No Abstract] [Full Text] [Related]
6. Editorial comments: endocrinology and metabolism 2015.
Root AW
Curr Opin Pediatr; 2015 Aug; 27(4):492-5. PubMed ID: 26087432
[No Abstract] [Full Text] [Related]
7. [Indications for corticotherapy in endocrine and metabolic pathology].
Baquet R
Maroc Med; 1969; 49(527):522-3. PubMed ID: 5398381
[No Abstract] [Full Text] [Related]
8. 30th International Symposium on GH and Growth Factors in Endocrinology and Metabolism. Monte Carlo, Monaco, October 6-7, 2000. Proceedings and abstracts.
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():1-160. PubMed ID: 11808495
[No Abstract] [Full Text] [Related]
9. Discontinued drugs in 2008: endocrine and metabolic.
Colca JR
Expert Opin Investig Drugs; 2009 Sep; 18(9):1243-55. PubMed ID: 19678796
[TBL] [Abstract][Full Text] [Related]
10. Discontinued drugs in 2005: endocrine and metabolic.
Colca JR
Expert Opin Investig Drugs; 2007 Feb; 16(2):129-36. PubMed ID: 17243934
[TBL] [Abstract][Full Text] [Related]
11. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use. Proceedings of a workshop. 26-27 November 2001.
Clin Infect Dis; 2003; 37 Suppl 2():S37-153. PubMed ID: 14569966
[No Abstract] [Full Text] [Related]
12. Correspondence (letter to the editor): Comment on the positive predictive value.
Wolter C
Dtsch Arztebl Int; 2011 Apr; 108(16):284; author reply 284. PubMed ID: 21603568
[No Abstract] [Full Text] [Related]
13. Unraveling the intricacies of receptor activated cell signaling and transcriptional cascades enhance opportunities to develop new therapeutic targets for endocrine and metabolic diseases.
Firestone GL
Curr Opin Pharmacol; 2010 Dec; 10(6):607-12. PubMed ID: 21036104
[No Abstract] [Full Text] [Related]
14. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use.
Khalsa JH; Genser S; Coates P; Francis H
Clin Infect Dis; 2003; 37 Suppl 2():S37-42. PubMed ID: 12942372
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of systemic glucocorticoid side effects.
Moghadam-Kia S; Werth VP
Int J Dermatol; 2010 Mar; 49(3):239-48. PubMed ID: 20465658
[TBL] [Abstract][Full Text] [Related]
16. Editorial overview: Endocrine and metabolic diseases: Waistline weapons: new therapeutic avenues for the treatment of obesity and metabolic disease.
Murphy KG
Curr Opin Pharmacol; 2015 Dec; 25():iv-vi. PubMed ID: 26559147
[No Abstract] [Full Text] [Related]
17. Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010-2019.
Liu X; Wu S; Sun J; Ni S; Lu L; Hu W; Wei H; Zou Y; Li T; Li J; Mijiti B; Fang P; Zhao L; Zhou H; Xing X; Niu H; Cao Y
Pharmacol Res Perspect; 2021 Apr; 9(2):e00729. PubMed ID: 33660404
[TBL] [Abstract][Full Text] [Related]
18. [Genetic basis of endocrine-metabolic diseases].
Taruscio D; Olivieri A
Ann Ist Super Sanita; 1999; 35(2):245-51. PubMed ID: 10645658
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological chaperones: potential treatment for conformational diseases.
Bernier V; Lagacé M; Bichet DG; Bouvier M
Trends Endocrinol Metab; 2004 Jul; 15(5):222-8. PubMed ID: 15223052
[TBL] [Abstract][Full Text] [Related]
20. Hormonal therapy in the future: a kinetic problem.
Crigler JF
Aust Paediatr J; 1979 Mar; 15 Spec No():7-16. PubMed ID: 380552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
